Overview


According to FutureWise analysis the market for diabetes ulcer treatment in 2023 is US$ 9.86 billion, and is expected to reach US$ 15.74 billion by 2031 at a CAGR of 6.00%.

A ulcer refers to a break or discontinuity in a bodily membrane which impedes the normal function of an affected organ. Ulcer refers to the rupture of the continuity between skin, epithelium and mucous membranes due to the expulsion of inflamed necrotic tissues. Diabetic foot ulcers can be a serious problem for diabetic patients. They can lead to amputations of the legs. People with diabetes who depend on insulin to manage their condition are at greater risk of developing a foot ulcer. People with the diabetes-related eye, kidney, or heart disease can also develop foot ulcers. The disease is more common in those who drink alcohol. Diabetic foot ulcer management includes the following: Liquidating the wound, applying daily saline or other similar dressings to keep them moist, debridement if necessary, antibiotics with surgical or non-surgical intervention if osteomyelitis is present, maintaining optimal blood pressure, and administering antibiotics with or without surgery if needed. You should look out for any redness, swelling, cracks, or sores as well as redness, white areas, thick callouses, discoloration, and other changes. You shouldn't just rely on the pain; even if you feel hotter or colder than normal, it could be a sign of an open wound. Due to the rising prevalence of diabetes ulcers will become more common.

Diabetic foot ulcers have become a serious health problem all around the globe. Diabetic patients seek cost-effective options to manage their diabetic ulcers. The market is expected to grow significantly over the forecast period due to recent advances in treatment therapy. This is due to the advancements in biomaterials for diabetic foot ulcer treatment, such as PLGA collagen, chitosan and skin substitutes, extracellular matrix protein, and other therapeutic agents. The growing demand for diabetic ulcer treatment will be met by the increasing number of companies involved in developing cutting-edge products. Market growth is likely to be slowed by a lack of knowledge about diabetic ulcer treatment options and the limited number of professionals who are trained in foot ulcer care. Market growth will be limited by the high cost of treating ulcers. Opportunities for growth are expected to arise from government initiatives to increase awareness about the existence of new treatment options on the market to treat diabetic ulcer management. The market will also benefit from the opportunity to grow its sales through geographic expansion products offered by key players. Diabetic ulcer treatment involves the use of various medical devices such as dressings, wound-care devices, and active therapies. These can be administered at home or in hospitals. The Diabetic Ulcers Treatment Market has seen a slightly negative effect . This can be attributed to disruptions in medical device supply chains, such as shortages of raw materials, disruptions in supply chains, and a shortage of skilled wound care professionals.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Diabetes Ulcer Treatment Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Diabetes Ulcer Treatment Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Integra Lifesciences Corporation
  • Smith and Nephew
  • Tissue Regenix
  • Colopast Corp
  • B.Braun
  • 3M
  • Cardinal Health
  • ConvaTec Group Plc
  • Molnlycke health Care AB

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Treatment Type

  • Wound care Dressings
    • Antimicrobial dressings
    • Film Dressings
    • Alginate Dressings
    • Others
  • Wound care Devices
    • Negative Pressure Wound Therapy
    • Hyperbaric oxygen Therapy
    • Ultrasound therapy
    • Others
  • Active Therapies
    • Skin Grafts and substitutes
    • Growth factors
    • Hemostatic Agents and Sealants
  • Others

By Ulcer Types

  • Neuropathic Ulcers
  • Ischemic Ulcers
  • Neuro-ischemic ulcers

By End User

  • Hospital inpaitent settings
  • Hospital outpatient settings
  • Community health centres
  • Home Health Care
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Diabetes Ulcer Treatment Market By Treatment Type, By Ulcer Types, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Diabetes Ulcer Treatment Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Diabetes Ulcer Treatment Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Diabetes Ulcer Treatment Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Diabetes Ulcer Treatment Market, By Treatment Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. wound care Dressings
         1.1. Antimicrobial dressings
         1.2. Film Dressings
         1.3. Alginate Dressings
         1.4. Others
        2. Wound care Devices
         2.1. Negative Pressure Wound Therapy
         2.2. Hyperbaric oxygen Therapy
         2.3. Ultrasound therapy
         2.4. Others
        3. Active Therapies
         3.1. Skin Grafts and substitutes
         3.2. Growth factors
         3.3. Hemostatic Agents and Sealants
        4. Others

  • 8.   Diabetes Ulcer Treatment Market, By Ulcer Types Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Neuropathic Ulcers
        2. Ischemic Ulcers
        3. Neuro-ischemic ulcers

  • 9.   Diabetes Ulcer Treatment Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospital inpaitent settings
        2. Hospital outpatient settings
        3. Community health centres
        4. Home Health Care
        5. Others

  • 10.   North America Diabetes Ulcer Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Diabetes Ulcer Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Diabetes Ulcer Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Diabetes Ulcer Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Integra Lifesciences Corporation
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Smith and Nephew
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Tissue Regenix
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Colopast Corp
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. B.Braun
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. 3M
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Cardinal Health
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. ConvaTec Group Plc
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Molnlycke health Care AB
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients